Silver Book Fact

An experimental drug has been found to extend the lives of kidney patients by about 3.5 months–from 7 to just under 11. It has also been shown to delay tumor growth. Patients lived a median of 3.7 months before their tumors got worse–as opposed to 1.9 months.

Szabo L. New Weapons Do Battle with Kidney Cancer. USA Today. June 4 2006. http://www.usatoday.com/news/health/2006-06-04-kidney-cancer_x.htm?csp=34

Reference

Title
New Weapons Do Battle with Kidney Cancer
Publication
USA Today
Publication Date
June 4 2006
Authors
Szabo L
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Pathogens cause around two million cancer cases worldwide each year. Ninety percent of these cases are attributable to Helicobacter pylori (H Pylori), hepatitis B virus (HBV), hepatitis C virus (HCV),…  
  • Studies have shown that annual mammograms reduce breast cancer related mortality in women by 20-40%.  
  • Close to one third of all drugs currently in the biopharmaceutical pipeline are for cancer, with around 5,500 potential first-in-class cancer medicines in development.  
  • Death rates from breast cancer have steadily decreased in women since 1990. This decrease represents progress in both early detection and improved treatment.  
  • Thousands of potential cancer medicines in development